AR072142A1 - Nutricion para prevenir infecciones.proceso. composicion. uso. - Google Patents
Nutricion para prevenir infecciones.proceso. composicion. uso.Info
- Publication number
- AR072142A1 AR072142A1 ARP090102157A ARP090102157A AR072142A1 AR 072142 A1 AR072142 A1 AR 072142A1 AR P090102157 A ARP090102157 A AR P090102157A AR P090102157 A ARP090102157 A AR P090102157A AR 072142 A1 AR072142 A1 AR 072142A1
- Authority
- AR
- Argentina
- Prior art keywords
- oligosacids
- incubated mixture
- preparation
- bifidobacteria
- thermophilus
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 14
- 238000000034 method Methods 0.000 title abstract 4
- 235000016709 nutrition Nutrition 0.000 title abstract 3
- 230000035764 nutrition Effects 0.000 title abstract 2
- 208000015181 infectious disease Diseases 0.000 title 1
- 238000002360 preparation method Methods 0.000 abstract 5
- 241000186000 Bifidobacterium Species 0.000 abstract 4
- 241000194020 Streptococcus thermophilus Species 0.000 abstract 4
- 239000000758 substrate Substances 0.000 abstract 4
- 239000005018 casein Substances 0.000 abstract 3
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 abstract 3
- 235000021240 caseins Nutrition 0.000 abstract 3
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 abstract 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 abstract 2
- 102000014171 Milk Proteins Human genes 0.000 abstract 2
- 108010011756 Milk Proteins Proteins 0.000 abstract 2
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 abstract 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 abstract 2
- 239000005862 Whey Substances 0.000 abstract 2
- 102000007544 Whey Proteins Human genes 0.000 abstract 2
- 108010046377 Whey Proteins Proteins 0.000 abstract 2
- 238000005119 centrifugation Methods 0.000 abstract 2
- 238000001914 filtration Methods 0.000 abstract 2
- 238000010438 heat treatment Methods 0.000 abstract 2
- 239000008101 lactose Substances 0.000 abstract 2
- 235000013336 milk Nutrition 0.000 abstract 2
- 239000008267 milk Substances 0.000 abstract 2
- 210000004080 milk Anatomy 0.000 abstract 2
- 235000021239 milk protein Nutrition 0.000 abstract 2
- LWGJTAZLEJHCPA-UHFFFAOYSA-N n-(2-chloroethyl)-n-nitrosomorpholine-4-carboxamide Chemical compound ClCCN(N=O)C(=O)N1CCOCC1 LWGJTAZLEJHCPA-UHFFFAOYSA-N 0.000 abstract 2
- 239000003531 protein hydrolysate Substances 0.000 abstract 2
- 235000018102 proteins Nutrition 0.000 abstract 2
- 102000004169 proteins and genes Human genes 0.000 abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 241000186012 Bifidobacterium breve Species 0.000 abstract 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical class OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 abstract 1
- MUPFEKGTMRGPLJ-RMMQSMQOSA-N Raffinose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-RMMQSMQOSA-N 0.000 abstract 1
- MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 235000021255 galacto-oligosaccharides Nutrition 0.000 abstract 1
- 150000003271 galactooligosaccharides Chemical class 0.000 abstract 1
- 230000000415 inactivating effect Effects 0.000 abstract 1
- 235000021125 infant nutrition Nutrition 0.000 abstract 1
- 150000002500 ions Chemical class 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 235000021140 nondigestible carbohydrates Nutrition 0.000 abstract 1
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 abstract 1
- 239000000377 silicon dioxide Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/733—Fructosans, e.g. inulin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
- A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
- A61K38/017—Hydrolysed proteins; Derivatives thereof from animals from blood
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
- A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
- A61K38/018—Hydrolysed proteins; Derivatives thereof from animals from milk
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Nutrition Science (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Pulmonology (AREA)
- Pediatric Medicine (AREA)
- Hematology (AREA)
- Pain & Pain Management (AREA)
- Dermatology (AREA)
- Rheumatology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Dairy Products (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Reivindicacion 1: Proceso para la fabricacion de una preparacion caracterizado porque comprende los siguientes pasos: (a) incubar un sustrato acuoso con bifidobacterias, conde el sustrato comprende al menos uno seleccionado del grupo que consiste en leche, prote¡nas de la leche, suero, prote¡nas sericas, hidrolizado de prote¡nas sericas, hidrolizado de case¡na y lactosa, para obtener una mezcla incubada; (b) inactivar las bifidobacterias mediante el calentamiento de la mezcla incubada y/o eliminar las celulas de las bifidobacterias de la mezcla incubada por centrifugacion y/o por filtracion; (c) combinar una composicion que comprende la mezcla obtenida en el paso (a) o la mezcla obtenida en el paso (b), preferiblemente la mezcla obtenida en el paso (b), con al menos dos hidratos de carbono no digeribles diferentes, donde al menos uno, preferiblemente dos se seleccionan del grupo que consiste en fructo-oligosac ridos, galacto-oligosac ridos, gluco-oligosac ridos, arabino-oligosac ridos, manano-oligosac ridos, xilo-oligosac ridos, fuco-oligosac ridos, arabinogalacto-oligosac ridos, glucomano-oligosac ridos, galactomano-oligosac ridos, rafinosa, lactosacarosa, oligosac ridos que comprenden cido si lico y oligosac ridos que comprenden cido uronico. Reivindicacion 3: Proceso de acuerdo con cualquiera de las reivindicaciones precedentes, caracterizado porque adicionalmente comprende los siguientes pasos: (d) incubar un sustrato con Streptococcus thermophilus, preferiblemente con la cepa CNCM I-1620 o con la cepa CNCM I-1470 de S. thermophilus, donde el sustrato se selecciona del grupo que consiste en leche, prote¡nas de la leche, suero, prote¡nas sericas, hidrolizado de prote¡nas sericas, case¡na, hidrolizado de case¡na y lactosa, para obtener una mezcla incubada; y (e) inactivar la S. thermophilus mediante el calentamiento de la mezcla incubada del paso (d) y/o eliminar las celulas de S. thermophilus de la mezcla incubada del paso (e) por centrifugacion y/o por filtracion; (f) combinar la mezcla incubada obtenida en el paso (d) o (e), preferiblemente en el paso (d), con la mezcla incubada obtenida en el paso (a), (b) o (c), preferiblemente en el paso (a). Reivindicacion 8: Preparacion caracterizada porque puede obtenerse con el proceso de acuerdo con cualquiera de las reivindicaciones precedentes. Reivindicacion 9: Composicion nutricional caracterizada porque comprende la preparacion de la reivindicacion 8, o que consiste en ella. Reivindicacion 11: Nutricion para lactantes caracterizada porque comprende (a) entre 0,5 y 10% en peso de la suma de galacto-oligosac ridos y fructo-oligosac ridos; y (b) entre 5 y 99,5% en peso de la preparacion obtenida despues del paso (b) de cualquiera de las reivindicaciones 1 a 5, donde las bifidobacterias en el paso (a) pertenecen a la especie B. breve; (c) y opcionalmente entre 2 y 94,5% en peso de la preparacion obtenida despues del paso (e ) de cualquiera de las reivindica':iones 3 a 6; sobre la base del peso seco de dicha nutricion para lactantes.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/NL2008/050375 WO2009151315A1 (en) | 2008-06-13 | 2008-06-13 | Nutritional composition for infants delivered via caesarean section |
| EP08168054 | 2008-10-31 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR072142A1 true AR072142A1 (es) | 2010-08-11 |
Family
ID=40935729
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP090102157A AR072142A1 (es) | 2008-06-13 | 2009-06-12 | Nutricion para prevenir infecciones.proceso. composicion. uso. |
| ARP090102156A AR072141A1 (es) | 2008-06-13 | 2009-06-12 | Composicion nutricional para lactantes nacidos por cesarea |
| ARP090102151A AR078014A1 (es) | 2008-06-13 | 2009-06-12 | Proceso para la fabricacion de una composicion nutricional estimuladora del sistema inmune |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP090102156A AR072141A1 (es) | 2008-06-13 | 2009-06-12 | Composicion nutricional para lactantes nacidos por cesarea |
| ARP090102151A AR078014A1 (es) | 2008-06-13 | 2009-06-12 | Proceso para la fabricacion de una composicion nutricional estimuladora del sistema inmune |
Country Status (13)
| Country | Link |
|---|---|
| US (5) | US20110097437A1 (es) |
| EP (4) | EP2285387B1 (es) |
| CN (3) | CN102118976B (es) |
| AR (3) | AR072142A1 (es) |
| BR (1) | BRPI0915149B1 (es) |
| DK (1) | DK2285387T3 (es) |
| ES (2) | ES2558960T3 (es) |
| HU (1) | HUE028390T2 (es) |
| PL (2) | PL2285387T3 (es) |
| PT (1) | PT2285387E (es) |
| RU (2) | RU2498605C2 (es) |
| SI (1) | SI2285387T1 (es) |
| WO (3) | WO2009151329A1 (es) |
Families Citing this family (58)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009072889A1 (en) * | 2007-12-07 | 2009-06-11 | N.V. Nutricia | Bifidobacterium for dust mite allergy |
| US20110097437A1 (en) | 2008-06-13 | 2011-04-28 | N.V. Nutricia | Nutrition for prevention of infections |
| RU2556124C2 (ru) | 2009-05-11 | 2015-07-10 | Нестек С.А. | Lactobacillus johnsonii La1 NСС533 (CNCM 1-1225) И ИММУННЫЕ НАРУШЕНИЯ |
| WO2011121379A1 (en) * | 2010-03-30 | 2011-10-06 | Assistance Publique - Hopitaux De Paris | Use of bifidobacteria for preventing allergy in breastfed infants |
| WO2011148221A1 (en) * | 2010-05-28 | 2011-12-01 | Compagnie Gervais Danone | Lactic acid bacteria for maturation of the enteric nervous system in infants |
| EP3097791B1 (en) * | 2010-06-04 | 2018-05-16 | N.V. Nutricia | Non-digestible oligosaccharides for oral induction of tolerance against dietary proteins |
| WO2011150949A1 (en) | 2010-06-04 | 2011-12-08 | N.V. Nutricia | Non-digestible oligosaccharides for oral induction of tolerance against dietary proteins |
| KR101757504B1 (ko) * | 2010-06-28 | 2017-07-12 | 가부시키가이샤 야쿠르트 혼샤 | 경구용 피부 성상 개선제 |
| WO2012057636A1 (en) * | 2010-10-27 | 2012-05-03 | Fonterra Corporate Research And Development Limited | Modulation of th1 and th2 immune response by lactic acid whey |
| EP2449891A1 (en) * | 2010-11-05 | 2012-05-09 | Nestec S.A. | Drinking yoghurt preparations containing non-replicating probiotic micro-organisms |
| AU2011328073A1 (en) * | 2010-11-11 | 2013-05-02 | Nestec S.A. | Frozen confections containing probiotic micro-organisms |
| EP2637510A1 (en) * | 2010-11-11 | 2013-09-18 | Nestec S.A. | Spoonable yogurt preparations containing non-replicating probiotic micro-organisms |
| EP2465508A1 (en) * | 2010-11-23 | 2012-06-20 | Nestec S.A. | Composition comprising hydrolysed proteins and oligosaccharides for treating skin diseases |
| WO2012078030A1 (en) * | 2010-12-06 | 2012-06-14 | N.V. Nutricia | Fermented infant formula |
| EP2520181A1 (en) * | 2011-05-02 | 2012-11-07 | N.V. Nutricia | Fermented infant formula |
| RU2600877C2 (ru) * | 2010-12-06 | 2016-10-27 | Н.В. Нютрисиа | Ферментированное детское питание |
| WO2012078032A1 (en) | 2010-12-10 | 2012-06-14 | N.V. Nutricia | Early stimulation of taste and/or flavour acceptance |
| EP3335576A1 (en) * | 2010-12-31 | 2018-06-20 | Abbott Laboratories | Human milk oligosaccharides to promote growth of beneficial bacteria |
| PL2481299T3 (pl) | 2011-01-31 | 2017-09-29 | Synformulas Gmbh | Szczepy bifidobacterium bifidum do stosowania w chorobach przewodu pokarmowego |
| US11446316B2 (en) | 2011-07-22 | 2022-09-20 | Abbott Laboratories | Galactooligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract |
| WO2013053073A1 (zh) * | 2011-10-10 | 2013-04-18 | Huang Daiyong | 一种基于甘露寡糖的胃肠道健康因子组合物 |
| WO2013187755A1 (en) * | 2012-06-14 | 2013-12-19 | N.V. Nutricia | Fermented infant formula with non digestible oligosaccharides |
| ES2884223T3 (es) * | 2012-11-02 | 2021-12-10 | Nutricia Nv | Combinación de simbióticos para la mejora del cerebro |
| JP6581509B2 (ja) | 2013-02-28 | 2019-09-25 | ティーウィノット テクノロジーズ リミテッド | 化合物を合成する化学工学プロセス及び装置 |
| US20140271978A1 (en) * | 2013-03-15 | 2014-09-18 | Mead Johnson Nutrition Company | Low-buffer nutritional compositions and uses thereof |
| US9352020B2 (en) * | 2013-03-15 | 2016-05-31 | Mead Johnson Nutrition Company | Reducing proinflammatory response |
| US20160089400A1 (en) * | 2013-04-08 | 2016-03-31 | N.V. Nutricia | Fermented nutritional composition with thiol protease inhibitor |
| WO2014200334A1 (en) * | 2013-06-14 | 2014-12-18 | N.V. Nutricia | Synbiotic composition for treatment of infections in allergic patients |
| CN104413334A (zh) * | 2013-08-30 | 2015-03-18 | 深圳华大基因科技有限公司 | 可食用组合物及其制备方法和用途 |
| EP2857410A1 (en) | 2013-10-04 | 2015-04-08 | Jennewein Biotechnologie GmbH | Process for purification of 2´-fucosyllactose using simulated moving bed chromatography |
| EP3068404B1 (en) | 2013-11-15 | 2021-01-06 | Société des Produits Nestlé S.A. | Compositions for use in the prevention or treatment of urt infections in infants or young children at risk |
| EP3082473A2 (en) * | 2013-12-19 | 2016-10-26 | Nestec S.A. | Nutritional composition to reduce metabolic stress in infants |
| BR112017003966A2 (pt) | 2014-08-25 | 2018-10-23 | Full Spectrum Laboratories Ltd | aparelhos e métodos para a produção simultânea de compostos canabinoides |
| EP3294308A4 (en) | 2015-05-14 | 2019-03-06 | University of Puerto Rico | PROCESS FOR RECOVERING THE BIOZOOSE OF NEWBORN |
| WO2017043962A1 (en) * | 2015-09-11 | 2017-03-16 | N.V. Nutricia | Method for stimulating microbiota health after non-natural birth |
| EP3150257A1 (en) * | 2015-09-30 | 2017-04-05 | Buga, Doris | A method for producing a composition for strengthening the immune system |
| CN105341938B (zh) * | 2015-10-10 | 2018-06-26 | 北京康比特体育科技股份有限公司 | 一种降低大强度运动后呼吸道感染率的保健食品 |
| US11564667B2 (en) | 2015-12-28 | 2023-01-31 | New York University | Device and method of restoring microbiota of newborns |
| BR112018013501B1 (pt) * | 2015-12-29 | 2022-12-20 | N.V. Nutricia | Uso de um ingrediente fermentado e oligossacarídeo não digerível |
| EP3397075A1 (en) * | 2015-12-29 | 2018-11-07 | N.V. Nutricia | Nutritional formula with non-digestible oligosaccharides and non-replicating lactic acid producing bacteria |
| WO2017194615A1 (en) | 2016-05-10 | 2017-11-16 | N.V. Nutricia | Fermented infant formula |
| CN109688839A (zh) | 2016-05-10 | 2019-04-26 | N·V·努特里奇亚 | 发酵的婴儿配方物 |
| CA3036494C (en) * | 2016-09-30 | 2022-10-18 | The A2 Milk Company Limited | Beta-caseins and gut microbiota |
| CN110573164B (zh) * | 2017-03-08 | 2023-09-29 | N·V·努特里奇亚 | 用于减轻鼻上皮炎症的含有不可消化的低聚糖的组合物 |
| AU2018295414A1 (en) * | 2017-07-07 | 2020-01-16 | Societe Des Produits Nestle S.A. | Human milk fortifier |
| CN107397230A (zh) * | 2017-08-21 | 2017-11-28 | 杭州特悘衡康生物科技有限公司 | 营养组合物、促进手术后肌肉恢复和蛋白质合成的配方食品及其应用 |
| US11197917B2 (en) | 2017-12-01 | 2021-12-14 | ByHeart, Inc. | Formulations for nutritional support in subjects in need thereof |
| WO2019115382A1 (en) * | 2017-12-11 | 2019-06-20 | N.V. Nutricia | Composition for use for treating delayed colonization by bifidobacterium after birth |
| CN111698993A (zh) | 2018-02-09 | 2020-09-22 | N·V·努特里奇亚 | 含有不可消化寡糖的发酵配方物 |
| WO2019155044A1 (en) | 2018-02-09 | 2019-08-15 | N.V. Nutricia | Fermented formula with non-digestible oligosaccharides |
| BR112021007249A2 (pt) | 2019-01-16 | 2021-08-10 | N.V. Nutricia | composições nutricionais |
| WO2020161113A1 (en) | 2019-02-04 | 2020-08-13 | N.V. Nutricia | Fermented formula with non digestible oligosaccharides for sleep improvement |
| CN113163835A (zh) | 2019-05-15 | 2021-07-23 | N·V·努特里奇亚 | 促进肠道发育的发酵配方物 |
| EP3975756A1 (en) * | 2019-05-29 | 2022-04-06 | N.V. Nutricia | Non-digestible oligosaccharides for decreased colonic protein fermentation |
| PT3883393T (pt) | 2019-06-04 | 2022-12-07 | Nutricia Nv | Composição nutricional compreendendo 2'fucosilactose e butirato dietético |
| EP4286014A3 (en) | 2019-06-04 | 2024-02-21 | N.V. Nutricia | Nutritional composition comprising 2'fucosyllactose and 3'galactosyllactose |
| CN110839698A (zh) * | 2019-11-29 | 2020-02-28 | 内蒙古伊利实业集团股份有限公司 | 一种组合物及其食品用途 |
| GB2608587A (en) * | 2021-06-25 | 2023-01-11 | Mjn Us Holdings Llc | Use of extensively hydrolysed protein |
Family Cites Families (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4110476A (en) | 1977-01-10 | 1978-08-29 | Johnson/Rhodes Cultured Foods, Inc. | Preparation of liquid and frozen yogurt products |
| RU2031586C1 (ru) * | 1993-02-05 | 1995-03-27 | Тамара Георгиевна Извекова | Биологически активный кисломолочный продукт "ацидолакт-наринэ" и способ его получения |
| FR2723963B1 (fr) * | 1994-08-31 | 1997-01-17 | Gervais Danone Co | Preparation de produits fermentes par streptococcus thermophilus, enrichis en galacto-oligosaccharides et en beta-galactosidase |
| EP1020123A1 (en) | 1999-01-18 | 2000-07-19 | Sitia-Yomo S.p.A. | Beverages containing live lactic bacteria |
| FR2795917B1 (fr) * | 1999-07-06 | 2001-08-31 | Gervais Danone Sa | Procede de preparation d'un produit lacte immunostimulant et ses applications |
| EP1062873A1 (en) * | 1999-12-13 | 2000-12-27 | N.V. Nutricia | Improved infant formula, protein hydrolysate for use in such an infant formula, and method for producing such a hydrolysate |
| DE60107544T2 (de) | 2000-03-01 | 2005-12-15 | Société des Produits Nestlé S.A. | Kohlenhydratformulierung (praebiotisches adjuvans) zur steigerung der immunantwort |
| EP1145643A1 (en) | 2000-04-10 | 2001-10-17 | Phillip Connolly | Improved milk protein concentrate |
| US7431939B1 (en) | 2000-09-28 | 2008-10-07 | Mississippi State University | Inhibition of systemic infections in humans and vertebrates by dietary fibers |
| EP1364586A1 (en) * | 2002-05-24 | 2003-11-26 | Nestec S.A. | Probiotics and oral tolerance |
| RU2220579C1 (ru) * | 2002-07-31 | 2004-01-10 | Зенович Сергей Михайлович | Пищевой преимущественно кисломолочный продукт и закваска для его получения (варианты) |
| OA13142A (en) * | 2002-10-11 | 2006-12-13 | Wyeth Corp | Nutritional formulations containing synbiotic substances. |
| GB0229015D0 (en) * | 2002-12-12 | 2003-01-15 | Novartis Nutrition Ag | New Compound |
| WO2004069156A2 (en) * | 2003-01-30 | 2004-08-19 | The Regents Of The University Of California | Inactivated probiotic bacteria and methods of use thereof |
| FR2857026B1 (fr) | 2003-04-16 | 2012-11-16 | Gervais Danone Sa | Produit immunomodulateur obtenu a partir d'une culture de bifidobacterium et compositions le contenant |
| FR2853908B1 (fr) * | 2003-04-16 | 2005-06-03 | Gervais Danone Sa | Produit immunomodulateur obtenu a partir d'une culture de bifidobacterium et compositions le contenant |
| CN1863463B (zh) * | 2003-06-23 | 2011-05-04 | 雀巢技术公司 | 用于促进肠道屏障成熟的营养组合物 |
| NZ546664A (en) * | 2003-10-24 | 2009-04-30 | Nutricia Nv | Synbiotic composition for infants |
| SG152271A1 (en) | 2003-10-24 | 2009-05-29 | Nutricia Nv | Immunemodulating oligosaccharides |
| EP1597978A1 (en) * | 2004-05-17 | 2005-11-23 | Nutricia N.V. | Synergism of GOS and polyfructose |
| US8252769B2 (en) | 2004-06-22 | 2012-08-28 | N. V. Nutricia | Intestinal barrier integrity |
| US7862808B2 (en) * | 2004-07-01 | 2011-01-04 | Mead Johnson Nutrition Company | Method for preventing or treating respiratory infections and acute otitis media in infants using Lactobacillus rhamnosus LGG and Bifidobacterium lactis Bb-12 |
| PL1841330T3 (pl) | 2004-12-27 | 2011-07-29 | Nestec Sa | Zastosowanie mieszanki dla niemowląt o obniżonej zawartości białka |
| EP1926394B1 (en) * | 2005-02-21 | 2020-02-19 | Société des Produits Nestlé S.A. | Oligosaccharide mixture |
| EP2351492B1 (en) * | 2005-02-28 | 2014-08-20 | N.V. Nutricia | Nutritional composition with probiotics |
| US7303745B2 (en) * | 2005-04-15 | 2007-12-04 | Bristol-Myers Squibb Company | Method for preventing or treating the development of respiratory allergies |
| EP1776877A1 (en) * | 2005-10-21 | 2007-04-25 | N.V. Nutricia | Method for stimulating the intestinal flora |
| WO2007067033A1 (en) | 2005-12-06 | 2007-06-14 | N.V. Nutricia | Composition containing oligosaccharides for the treatment/ prevention of infections |
| CA2636181A1 (en) | 2006-01-11 | 2007-07-19 | Attune Foods | Probiotic food, process for its preparation and dietary regimen |
| WO2008153377A1 (en) | 2007-06-15 | 2008-12-18 | N.V. Nutricia | Nutrition with non-viable bifidobacterium and non-digestible oligosaccharide |
| US20110097437A1 (en) * | 2008-06-13 | 2011-04-28 | N.V. Nutricia | Nutrition for prevention of infections |
| WO2010008272A1 (en) | 2008-07-15 | 2010-01-21 | N.V. Nutricia | Treatment of gut motility disorders |
| WO2010070613A2 (en) | 2008-12-18 | 2010-06-24 | University College London | Baby feeding formula and system |
| EP2520181A1 (en) | 2011-05-02 | 2012-11-07 | N.V. Nutricia | Fermented infant formula |
| RU2600877C2 (ru) | 2010-12-06 | 2016-10-27 | Н.В. Нютрисиа | Ферментированное детское питание |
| WO2012078030A1 (en) | 2010-12-06 | 2012-06-14 | N.V. Nutricia | Fermented infant formula |
| MX2011007872A (es) | 2011-07-26 | 2013-01-29 | Nucitec Sa De Cv | Composicion nutrimental para niños que presentan reflujo, colico y/o estreñimiento. |
-
2009
- 2009-06-12 US US12/997,541 patent/US20110097437A1/en not_active Abandoned
- 2009-06-12 EP EP09762710.3A patent/EP2285387B1/en active Active
- 2009-06-12 CN CN200980131387.1A patent/CN102118976B/zh active Active
- 2009-06-12 PL PL09762710T patent/PL2285387T3/pl unknown
- 2009-06-12 EP EP17205129.4A patent/EP3326633A1/en not_active Withdrawn
- 2009-06-12 US US12/997,537 patent/US20110117077A1/en not_active Abandoned
- 2009-06-12 RU RU2011100829/10A patent/RU2498605C2/ru active
- 2009-06-12 AR ARP090102157A patent/AR072142A1/es unknown
- 2009-06-12 CN CN200980131512.9A patent/CN102123715B/zh active Active
- 2009-06-12 WO PCT/NL2009/050330 patent/WO2009151329A1/en active Application Filing
- 2009-06-12 SI SI200931354T patent/SI2285387T1/sl unknown
- 2009-06-12 BR BRPI0915149-4A patent/BRPI0915149B1/pt active IP Right Grant
- 2009-06-12 PT PT97627103T patent/PT2285387E/pt unknown
- 2009-06-12 DK DK09762710.3T patent/DK2285387T3/en active
- 2009-06-12 WO PCT/NL2009/050332 patent/WO2009151330A1/en active Application Filing
- 2009-06-12 PL PL09762711T patent/PL2293677T3/pl unknown
- 2009-06-12 EP EP09762711.1A patent/EP2293677B1/en active Active
- 2009-06-12 HU HUE09762710A patent/HUE028390T2/en unknown
- 2009-06-12 AR ARP090102156A patent/AR072141A1/es unknown
- 2009-06-12 CN CN2009801222425A patent/CN102065867A/zh active Pending
- 2009-06-12 RU RU2011100828/15A patent/RU2543634C2/ru active
- 2009-06-12 EP EP09762712A patent/EP2293803A1/en not_active Ceased
- 2009-06-12 US US12/997,527 patent/US20110182934A1/en not_active Abandoned
- 2009-06-12 ES ES09762710.3T patent/ES2558960T3/es active Active
- 2009-06-12 WO PCT/NL2009/050333 patent/WO2009151331A1/en active Application Filing
- 2009-06-12 AR ARP090102151A patent/AR078014A1/es unknown
- 2009-06-12 ES ES09762711.1T patent/ES2656776T3/es active Active
-
2016
- 2016-09-28 US US15/278,475 patent/US20170173104A1/en not_active Abandoned
-
2017
- 2017-01-13 US US15/406,361 patent/US10124016B2/en active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR072142A1 (es) | Nutricion para prevenir infecciones.proceso. composicion. uso. | |
| NO20074278L (no) | Tigecyklinblandinger og fremgangsmater for fremstilling | |
| Wang et al. | Evaluation of the basic functions of six calcium-dependent protein kinases in Toxoplasma gondii using CRISPR-Cas9 system | |
| Debur et al. | Human metapneumovirus infection in hematopoietic stem cell transplant recipients | |
| AR067020A1 (es) | Alimento nutritivo con bifidobacteria no viable y oligosacarido no digerible | |
| BRPI0519626A2 (pt) | mÉtodos para a reduÇço do teor de um ou mais contaminantes, do teor de proteÍna s em uma composiÇço, do teor de um ou mais contaminantes de proteÍna em um sobrenadante de cultura de cÉlula, do teor de proteÍna s em um sobrenadante de cultura de cÉlula, composiÇço compreendendo uma proteÍna dependente de vitamina k de interesse | |
| Stokol et al. | Equid herpesvirus type 1 activates platelets | |
| Hartwig et al. | Depletion of alveolar macrophages ameliorates virus-induced disease following a pulmonary coronavirus infection | |
| BR112017026514A2 (pt) | métodos e sistemas para extrair produtos ricos em proteínas e carboidratos de uma microcultura e composições dos mesmos | |
| RU2013151165A (ru) | Детская смесь для применения в профилактике сердечно-сосудистых заболеваний | |
| Furlund et al. | Bovine lactoferrin digested with human gastrointestinal enzymes inhibits replication of human echovirus 5 in cell culture | |
| CN106497791B (zh) | 一种金黄色葡萄球菌冻干制备用新型复合保护剂 | |
| Savoie et al. | Optimizing human coronavirus OC43 growth and titration | |
| CL2013001601A1 (es) | Proceso para licuar una o mas proteinas de cereal, que comprende las etapas de : a) suministrar una composicion que comprende una o mas de proteinas de cereal de un 5-40% en peso de materia seca; b) añadir una o mas enzimas hidroliticas y/o auxiliares de procesamiento; c) opcionalmente, preacondicionar; d) homogeneizar; ademas opcionalmente pretratar la composicion obtenida, e incubar la composicion a una temperatura de 50-85 grados celsius durante al menos 5 minutos. | |
| Boffa et al. | The action of Vipera aspis venom on blood clotting factors and platelets | |
| Pokrovska et al. | Predictors of influenza A and influenza B in children 3-18 years in epidemic seasons 2017-2018 and 2018-2019 | |
| AR112851A1 (es) | Procedimiento para la obtención de una glicoproteína con un mayor porcentaje de glicanos afucosilados | |
| Lynch et al. | Mediated trehalose un-loading for reduced erythrocyte osmotic fragility and phosphatidylserine translocation | |
| Kong et al. | Purification and identification of lactoferrin from bovine milk | |
| Forbi et al. | Urban-rural estimation of hepatitis C virus infection sero-prevalence in north Central Nigeria | |
| Chen et al. | Influence of fluoride on caspase-3 expression in kidney of rats fed a normal or a low calcium and protein diet and its reversal by protein and calcium supplementation | |
| Kumar et al. | Isolation of goat pox virus from Durg district of Chhattisgarh | |
| McKenzie | Membrane microdomains as therapeutic targets to control respiratory syncytial virus | |
| Shakhmardanov et al. | Epidemiology of COVID-19 | |
| Silva et al. | Viral respiratory infections in adult patients treated in the emergency room |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |